It is possible that the main title of the report Ferroportin Disease is not the name you expected. Please check the synonyms listing to find the alternate name(s) and disorder subdivision(s) covered by this report.
Ferroportin disease, also known as hemochromatosis type 4, is a rare genetic disorder characterized by the abnormal accumulation of iron in the body. Ferroportin disease is caused by mutations of the SLC40A1 gene. The specific symptoms associated with ferroportin disease can vary greatly from one person to another. Some individuals may only have elevated levels of ferritin, a protein that binds to iron and is used as an indicator of the body's iron stores in the blood plasma. Other individuals may develop symptoms similar to classic hereditary hemochromatosis
Ferroportin disease is classified as an iron overload disorder, a group of disorders characterized by the abnormal accumulation of iron in the body. It is a separate, distinct disorder from classic hereditary hemochromatosis. Ferroportin disease is caused by mutations to a different gene and is inherited in a different manner from other forms of hemochromatosis.
Iron Overload Diseases Association, Inc.
525 Mayflower Rd.
West Palm Bch, Fl 33405
NIH/National Institute of Diabetes, Digestive & Kidney Diseases
Office of Communications & Public Liaison
Bldg 31, Rm 9A06
31 Center Drive, MSC 2560
Bethesda, MD 20892-2560
Canadian Hemochromatosis Society
7000 Minoru Blvd Suite 272
British Columbia, Intl V6Y 3Z5
Tel: (604) 279-7135
Fax: (604) 279-7138
Tel: (877) 223-4766
American Hemochromatosis Society
4044 W. Lake Mary Blvd.
Suite 104 PMB 416
Lake Mary, FL 32746-2012
Iron Disorders Institute
PO Box 675
Taylors, SC 29687